Edmunds White Partners’s AbbVie ABBV Stock Holding History

Edmunds White Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-175	Closed	-$8K	–	39
2013 Q2	$8K	Buy	+175	New	+$7.65K	0.01%	48

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Edmunds White Partners's ABBV Position: Q3 2013 in Review

Edmunds White Partners sold out of AbbVie (ABBV) in Q3 2013, closing a stake of 175 shares — an estimated $8K sold.

Edmunds White Partners first reported a position in ABBV in Q2 2013 and held it in 1 quarter. The position peaked at $8K in Q2 2013. 1,296 funds tracked by Wall St. Rank hold ABBV as of Q3 2013.

Edmunds White Partners reported no remaining AbbVie position as of Q3 2013 after selling out during the quarter.
Edmunds White Partners sold 175 AbbVie shares in Q3 2013, an estimated $8K.
Edmunds White Partners first reported a position in AbbVie in Q2 2013 and held it in 1 quarter.
Edmunds White Partners's AbbVie position peaked at $8K in Q2 2013.
1,296 funds tracked by Wall St. Rank held AbbVie as of Q3 2013.

Based on Edmunds White Partners's 13F filing for Q3 2013, filed 25 Oct 2013.